CVE-2023-6078 json
OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023
published 2024-02-01 2 y ago modified 2026-06-17 4 mo ago also EUVD-2023-58334
- cvss
- 8.8
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 1.6%
- EPSS 1.6% chance of exploitation in 30 days, percentile 76%
- public exploits
- 0
- none known
Summary
An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 2 y ago
Exploit prediction
1.64% chance of exploitation in the next 30 days, higher than 76% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 8.8 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
| NVD | 3.1 | 9.8 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
Affected products
- Dassault Systèmes BIOVIA Materials Studio products
Classification
- Weakness
-
- CWE-78 Improper Neutralization of Special Elements used in an OS Command
References
-
3ds.com
/vulnerability/advisories
vendor-advisory
Sources
- CVE List CVE-2023-6078
- NVD CVE-2023-6078
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.